TG Therapeutics (TGTX) Stock Forecast, Price Target & Predictions
TGTX Stock Forecast
TG Therapeutics stock forecast is as follows: an average price target of $23.75 (represents a -26.91% downside from TGTX’s last price of $32.49) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
TGTX Price Target
TGTX Analyst Ratings
Buy
TG Therapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 05, 2024 | Edward White | H.C. Wainwright | $27.50 | $12.93 | 112.68% | -15.37% |
Aug 06, 2024 | Corinne Jenkins | Goldman Sachs | $20.00 | $20.58 | -2.82% | -38.45% |
May 03, 2024 | Edward White | H.C. Wainwright | $24.50 | $8.21 | 198.42% | -24.60% |
Feb 07, 2023 | Cantor Fitzgerald | $24.00 | $18.48 | 29.87% | -26.14% | |
Dec 30, 2022 | Evercore ISI | $16.00 | $11.83 | 35.25% | -50.76% | |
Dec 29, 2022 | Edward White | H.C. Wainwright | $12.00 | $4.23 | 183.69% | -63.07% |
Apr 19, 2022 | Goldman Sachs | $5.00 | $7.26 | -31.13% | -84.61% | |
Apr 18, 2022 | Mayank Mamtani | Telsey Advisory | $11.50 | $3.46 | 232.37% | -64.61% |
TG Therapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 3 |
Avg Price Target | - | $27.50 | $24.00 |
Last Closing Price | $32.49 | $32.49 | $32.49 |
Upside/Downside | -100.00% | -15.37% | -26.14% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 29, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Oct 29, 2024 | Cowen & Co. | Buy | Initialise | |
Oct 24, 2024 | B. Riley | Buy | Buy | Hold |
Sep 18, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 06, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
May 03, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Aug 02, 2023 | Goldman Sachs | Sell | Neutral | Upgrade |
Dec 30, 2022 | Jefferies | Buy | Buy | Hold |
Dec 30, 2022 | Goldman Sachs | Sell | Sell | Hold |
Dec 30, 2022 | Evercore ISI | Outperform | Outperform | Hold |
Dec 30, 2022 | B. Riley Securities | Buy | Buy | Hold |
Dec 29, 2022 | B. Riley | Buy | Buy | Hold |
Dec 29, 2022 | Morgan Stanley | Underperform | Underperform | Hold |
Dec 29, 2022 | H.C. Wainwright | Buy | Buy | Hold |
TG Therapeutics Financial Forecast
TG Therapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $43.97M | $165.81M | $16.07M | $7.80M | $80.00K | $94.00K | $594.00K | $2.02M | $2.32M | $2.03M | $1.54M | $793.00K | $38.00K | $38.00K | $38.00K | $38.00K | $38.00K | $38.00K | $38.00K | $38.00K |
Avg Forecast | $172.50M | $144.77M | $128.56M | $112.93M | $98.26M | $81.70M | $65.92M | $54.60M | $40.06M | $23.91M | $17.39M | $3.38M | $1.60M | $1.46M | $175.43K | $2.08M | $2.24M | $2.97M | $3.60M | $820.29K | $19.00K | $19.00K | $22.80K | $22.80K | $22.80K | $34.50K | $19.00K | $25.33K |
High Forecast | $181.17M | $152.04M | $135.02M | $117.68M | $103.75M | $81.94M | $65.92M | $54.60M | $40.18M | $23.91M | $18.27M | $3.55M | $1.68M | $1.46M | $175.43K | $2.08M | $2.24M | $2.97M | $3.60M | $820.29K | $19.00K | $19.00K | $22.80K | $22.80K | $22.80K | $34.50K | $19.00K | $25.33K |
Low Forecast | $165.47M | $138.86M | $123.32M | $108.17M | $95.30M | $81.47M | $65.92M | $54.60M | $39.88M | $23.91M | $16.68M | $3.24M | $1.54M | $1.46M | $175.43K | $2.08M | $2.24M | $2.97M | $3.60M | $820.29K | $19.00K | $19.00K | $22.80K | $22.80K | $22.80K | $34.50K | $19.00K | $25.33K |
# Analysts | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | 1.10% | 6.93% | 0.92% | 2.31% | 0.05% | 0.06% | 3.39% | 0.97% | 1.04% | 0.68% | 0.43% | 0.97% | 2.00% | 2.00% | 1.67% | 1.67% | 1.67% | 1.10% | 2.00% | 1.50% |
Forecast
TG Therapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | $-12.48M | $114.78M | $-43.98M | $-36.39M | $-50.13M | $-34.04M | $-37.49M | $-66.22M | $-92.18M | $-84.52M | $-76.81M | $-88.67M | $-86.87M | $-85.51M | $-50.62M | $-49.88M | $-37.65M | $-60.37M | $-35.11M | $-35.13M |
Avg Forecast | $-134.15M | $-112.58M | $-99.98M | $-87.82M | $-76.42M | $-63.54M | $-51.27M | $-42.46M | $-31.16M | $-18.60M | $-13.53M | $-2.63M | $-1.25M | $-1.14M | $-137.18K | $-49.39M | $-1.75M | $-2.32M | $-2.82M | $-57.73M | $-14.86K | $-66.09M | $-17.83K | $-17.83K | $-17.83K | $-26.98K | $-14.86K | $-19.81K |
High Forecast | $-128.68M | $-107.99M | $-95.90M | $-84.12M | $-74.11M | $-63.36M | $-51.27M | $-42.46M | $-31.02M | $-18.60M | $-12.97M | $-2.52M | $-1.20M | $-1.14M | $-137.18K | $-39.51M | $-1.75M | $-2.32M | $-2.82M | $-46.18M | $-14.86K | $-52.87M | $-17.83K | $-17.83K | $-17.83K | $-26.98K | $-14.86K | $-19.81K |
Low Forecast | $-140.89M | $-118.24M | $-105.00M | $-91.52M | $-80.68M | $-63.72M | $-51.27M | $-42.46M | $-31.25M | $-18.60M | $-14.20M | $-2.76M | $-1.31M | $-1.14M | $-137.18K | $-59.26M | $-1.75M | $-2.32M | $-2.82M | $-69.27M | $-14.86K | $-79.30M | $-17.83K | $-17.83K | $-17.83K | $-26.98K | $-14.86K | $-19.81K |
Surprise % | - | - | - | - | - | - | - | - | 0.40% | -6.17% | 3.25% | 13.85% | 40.19% | 29.90% | 273.31% | 1.34% | 52.63% | 36.42% | 27.25% | 1.54% | 5847.34% | 1.29% | 2839.31% | 2797.97% | 2111.45% | 2237.64% | 2363.40% | 1773.59% |
Forecast
TG Therapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | $-14.42M | $113.93M | $-47.61M | $-38.63M | $-53.92M | $-36.67M | $-42.08M | $-71.15M | $-93.73M | $-86.15M | $-79.50M | $-92.05M | $-89.65M | $-88.60M | $-54.92M | $-51.99M | $-41.18M | $-63.00M | $-36.88M | $-35.62M |
Avg Forecast | $61.15M | $46.85M | $36.77M | $25.06M | $13.09M | $4.82M | $-7.33M | $-9.64M | $-16.11M | $9.19M | $-40.42M | $-58.26M | $-43.57M | $-56.60M | $-76.52M | $-51.45M | $-101.23M | $-90.87M | $-82.90M | $-59.00M | $-95.43M | $-67.36M | $-53.89M | $-57.07M | $-73.02M | $-53.81M | $-64.83M | $-69.35M |
High Forecast | $65.15M | $49.91M | $39.17M | $26.69M | $20.57M | $5.14M | $-6.94M | $-9.13M | $-13.43M | $9.79M | $-38.27M | $-55.17M | $-41.26M | $-56.60M | $-76.52M | $-41.16M | $-101.23M | $-90.87M | $-82.90M | $-47.20M | $-95.43M | $-53.89M | $-53.89M | $-57.07M | $-73.02M | $-53.81M | $-64.83M | $-69.35M |
Low Forecast | $57.91M | $44.36M | $34.82M | $22.27M | $11.22M | $4.57M | $-7.81M | $-10.27M | $-17.46M | $8.70M | $-43.06M | $-62.06M | $-46.42M | $-56.60M | $-76.52M | $-61.74M | $-101.23M | $-90.87M | $-82.90M | $-70.80M | $-95.43M | $-80.83M | $-53.89M | $-57.07M | $-73.02M | $-53.81M | $-64.83M | $-69.35M |
Surprise % | - | - | - | - | - | - | - | - | 0.89% | 12.40% | 1.18% | 0.66% | 1.24% | 0.65% | 0.55% | 1.38% | 0.93% | 0.95% | 0.96% | 1.56% | 0.94% | 1.32% | 1.02% | 0.91% | 0.56% | 1.17% | 0.57% | 0.51% |
Forecast
TG Therapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | $31.15M | $26.50M | $36.38M | $29.65M | $28.26M | $17.50M | $14.97M | $22.50M | $56.46M | $34.90M | $34.02M | $26.76M | $43.86M | $35.30M | $14.43M | $14.26M | $7.06M | $2.91M | $2.72M | $2.34M |
Avg Forecast | $34.21B | $28.71B | $25.50B | $22.40B | $19.49B | $16.20B | $13.07B | $10.83B | $7.95B | $4.74B | $3.45B | $670.15M | $318.16M | $288.71M | $34.79M | $412.66M | $444.22M | $588.55M | $714.97M | $162.69M | $3.77M | $3.77M | $4.52M | $4.52M | $4.52M | $6.84M | $3.77M | $5.02M |
High Forecast | $35.93B | $30.15B | $26.78B | $23.34B | $20.58B | $16.25B | $13.07B | $10.83B | $7.97B | $4.74B | $3.62B | $703.83M | $334.15M | $288.71M | $34.79M | $412.66M | $444.22M | $588.55M | $714.97M | $162.69M | $3.77M | $3.77M | $4.52M | $4.52M | $4.52M | $6.84M | $3.77M | $5.02M |
Low Forecast | $32.82B | $27.54B | $24.46B | $21.45B | $18.90B | $16.16B | $13.07B | $10.83B | $7.91B | $4.74B | $3.31B | $642.81M | $305.18M | $288.71M | $34.79M | $412.66M | $444.22M | $588.55M | $714.97M | $162.69M | $3.77M | $3.77M | $4.52M | $4.52M | $4.52M | $6.84M | $3.77M | $5.02M |
Surprise % | - | - | - | - | - | - | - | - | 0.00% | 0.01% | 0.01% | 0.04% | 0.09% | 0.06% | 0.43% | 0.05% | 0.13% | 0.06% | 0.05% | 0.16% | 11.64% | 9.37% | 3.19% | 3.15% | 1.56% | 0.43% | 0.72% | 0.47% |
Forecast
TG Therapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 5 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | $-0.10 | $0.80 | $-0.34 | $-0.28 | $-0.39 | $-0.27 | $-0.31 | $-0.53 | $-0.71 | $-0.65 | $-0.60 | $-0.70 | $-0.72 | $-0.74 | $-0.49 | $-0.49 | $-0.43 | $-0.70 | $-0.42 | $-0.44 |
Avg Forecast | $0.38 | $0.29 | $0.23 | $0.16 | $0.08 | $0.03 | $-0.05 | $-0.06 | $-0.10 | $0.06 | $-0.25 | $-0.36 | $-0.27 | $-0.35 | $-0.48 | $-0.61 | $-0.64 | $-0.57 | $-0.52 | $-0.56 | $-0.60 | $-0.41 | $-0.34 | $-0.36 | $-0.46 | $-0.34 | $-0.41 | $-0.43 |
High Forecast | $0.41 | $0.31 | $0.24 | $0.17 | $0.13 | $0.03 | $-0.04 | $-0.06 | $-0.08 | $0.06 | $-0.24 | $-0.34 | $-0.26 | $-0.35 | $-0.48 | $-0.61 | $-0.64 | $-0.57 | $-0.52 | $-0.56 | $-0.60 | $-0.41 | $-0.34 | $-0.36 | $-0.46 | $-0.34 | $-0.41 | $-0.43 |
Low Forecast | $0.36 | $0.28 | $0.22 | $0.14 | $0.07 | $0.03 | $-0.05 | $-0.06 | $-0.11 | $0.05 | $-0.27 | $-0.39 | $-0.29 | $-0.35 | $-0.48 | $-0.61 | $-0.64 | $-0.57 | $-0.52 | $-0.56 | $-0.60 | $-0.41 | $-0.34 | $-0.36 | $-0.46 | $-0.34 | $-0.41 | $-0.43 |
Surprise % | - | - | - | - | - | - | - | - | 1.00% | 14.00% | 1.35% | 0.77% | 1.44% | 0.76% | 0.65% | 0.87% | 1.12% | 1.14% | 1.15% | 1.26% | 1.20% | 1.79% | 1.45% | 1.37% | 0.94% | 2.07% | 1.03% | 1.01% |
Forecast
TG Therapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
HEPA | Hepion Pharmaceuticals | $0.52 | $70.00 | 13361.54% | Buy |
XFOR | X4 Pharmaceuticals | $0.74 | $3.67 | 395.95% | Buy |
PDSB | PDS Bio | $1.96 | $9.00 | 359.18% | Buy |
TERN | Terns Pharmaceuticals | $6.80 | $18.67 | 174.56% | Buy |
BTAI | BioXcel Therapeutics | $0.39 | $1.00 | 156.41% | Buy |
VKTX | Viking Therapeutics | $46.70 | $97.80 | 109.42% | Buy |
AKRO | Akero Therapeutics | $30.61 | $50.00 | 63.35% | Buy |
MDGL | Madrigal Pharmaceuticals | $306.08 | $315.75 | 3.16% | Buy |
EXEL | Exelixis | $34.69 | $30.89 | -10.95% | Buy |
TGTX | TG Therapeutics | $33.57 | $23.75 | -29.25% | Buy |